News & Updates
Filter by Specialty:
PrEP use tied to ‘stable’ STI incidence, sexual behaviour among MSM
The incidence of sexually transmitted infection (STI) over the first 4 years of pre-exposure prophylaxis (PrEP) use remains high and stable, but the incidence of chlamydia and gonorrhea has slightly decreased among daily PrEP users, as shown in a study presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI).
PrEP use tied to ‘stable’ STI incidence, sexual behaviour among MSM
27 Feb 2023
Adipose tissue–targeted nanoparticles may improve treatment of obesity and atherosclerosis
Researchers from the University of Hong Kong (HKU) have developed a nanoparticle-based targeted drug delivery system that selectively transports thyroid hormone (TH) to adipose tissue, which may improve treatment of obesity and its related cardiometabolic complications by overcoming serious adverse events (AEs) associated with systematic TH administration.
Adipose tissue–targeted nanoparticles may improve treatment of obesity and atherosclerosis
27 Feb 2023
Tirofiban improves functional outcome, prevents haemorrhage in stroke patients
Endovascular treatment (EVT) with intravenous tirofiban prior to thrombectomy appears to improve functional outcome and reduce the risk of any intracranial haemorrhage in patients with large vessel occlusion treated within 4.5 hours after stroke onset compared with alteplase, a study has shown.
Tirofiban improves functional outcome, prevents haemorrhage in stroke patients
26 Feb 2023
Zinc supplements may improve survival in nonmetastatic prostate cancer
Postdiagnostic use of low-dose zinc supplement may help reduce the risk of lethal prostate cancer and all-cause mortality among patients with nonmetastatic prostate cancer, suggests a recent study.
